$2000 | Single User
$2500 | Site License
$2500 | Enterprise License

Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022
[Published by DPI Research]

Published by DPI Research: 21 Nov 2016 | 28551 | In Stock
Related Topics: AstraZeneca , GlaxoSmithKline , Protein , Vaccine

Introduction

Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding the threat of influenza and the importance of influenza vaccinations, high investment and strict regulations act as barriers for new entrants.

The United States seasonal influenza vaccine market is the most attractive of those covered in the report. The United States market for seasonal influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. United Kingdom will be the second–largest market for seasonal influenza vaccine which is expected to grow at a CAGR of XX% by 2022. Germany is expected to be third largest seasonal influenza vaccine market being followed by Japan by the end of the forecasted period.

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the seasonal influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the seasonal influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into seasonal influenza vaccine sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in seasonal influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players in the seasonal influenza vaccine market such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook, and sales analysis of seasonal influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of seasonal influenza vaccine market.

Seven Major Markets(7MM) covered in the report are as follows:


1. United States

2. United Kingdom

3. France

4. Italy

5. Spain

6. Germany

7. Japan


Major and Promising Vaccines covered in the report are as follows:


1. Fluzone High–Dose

2. Fluzone Quadrivalent

3. Intradermal (ID) Trivalent

4. Vaxigrip

5. Fluarix Quadrivalent

6. Flulaval Quadrivalent

7. Fluenz Tetra

8. FluMist Quadrivalent

9. Flublok

10. VN–100

11. M–001

12. VAX–2012Q

13. TAK – 850

14. Flucelvax Quadrivalent

15. Afluria Quadrivalent

16. Agrippal

17. Fluad

18. Fluvirin

19. Fluvax

Seasonal Influenza Vaccine Report is segmented with 10 Chapters:

Chapter 1: Chapter one is the introduction with Executive Summary

Chapter 2: Chapter two provides overall recent and forecasts data for the seasonal influenza vaccine market in the top seven countries. This Chapter divided into 4 parts

1. Overall seasonal influenza vaccine market data from 2010 to 2022

2. Overall number of persons vaccinated with seasonal influenza vaccine data from 2010 to 2022

3. Seasonal influenza vaccine market share in the top seven countries data from 2010 to 2022

4. Persons being vaccinated with influenza vaccine share in the top seven countries data from 2010 to 2022

Chapter 3: Key market drivers and barriers in the seasonal influenza vaccine market.

Chapter 4: Chapter four gives detailed recent and forecasts for the seasonal influenza vaccine markets in the US, the UK, France, Italy, Spain, Germany and Japan, comprising of market size, total number of persons vaccinated, number of children vaccinated, number of 60+ years of age persons vaccinated, number of pregnant women vaccinated, number of chronic medical condition persons vaccinated, number of healthcare workers vaccinated and vaccination coverage.

Chapter 5: Chapter five gives detailed information on seasonal influenza vaccine production & distribution in United States. The information includes vaccine choices remain available for patients, providers, prices of a dose of vaccine, production, supply, and allocation by the major seasonal influenza vaccine manufacturers, seasonal influenza vaccine distribution & demand, seasonal influenza vaccine effectiveness, managing influenza with diagnostic resources, distribution method of seasonal influenza vaccination.

Chapter 6: Chapter six offers information about regulatory landscape including the approval process and an overview of the regulatory authorities in the United States, EU and Japan.

Chapter 7: Chapter seven highlights key M&A deals that took place in the seasonal influenza vaccine market between 2003 and 2015 and lists the major collaborations, licensing, exclusive and distribution agreements deals.


Chapter 8: Chapter eight provides detailed pipeline influenza vaccines in various companies’ pipelines with clinical development and early stage development vaccines.

Chapter 9: Chapter nine offers detailed information of the recruiting clinical trials statement by phase, trial status, study sponsor name and study phase.

Chapter 10: Chapter ten gives information on the key players in the market with business overview, product outlook and sales analysis of the seasonal influenza vaccine.

Table of Contents
for Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022 [Published by DPI Research]

  • List of Tables

    Table 5–1: United States Seasonal Influenza Vaccine Available,2016 – 17

    Table 5–2: United States – Pediatric Seasonal Influenza Vaccine Price, 2016 – 2017

    Table 5–3: United States – Adult Seasonal Influenza Vaccine Price, 2016 – 2017

    Table 5–4: United States – Flu Vaccine Production, Supply, and Allocation

    Table 5–5: Total Percentage of Flu Vaccines Released by Week,2016 – 2017

    Table 5–6: Total Percentage of Flu Vaccines Released by Week,2015 – 2016

    Table 5–7: Total Percentage of Flu Vaccines Released by Week,2014 – 2015

    Table 5–8: Adjusted Vaccine Effectiveness Estimates for Influenza Seasons, 2005 – 2016

    Table 5–9: Managing Influenza with Diagnostic Resources

    Table 5–10: Distribution of Seasonal Influenza Vaccination

    Table 6–1: United States – Simplified Regulatory Pathway from Preclinical to the Marketing Authorization

    Table 6–2: European Union – Simplified Regulatory Pathway from Preclinical to the Marketing Authorization

    Table 6–3: Japan – Simplified Regulatory Pathway from Preclinical to the Marketing Authorization

    Table 7–1: Influenza Vaccine Market – Merger & Acquisitions (Million US$),2003 – 2015

    Table 7–2: Influenza Vaccine Market – Collaborations Deal,2007 – 2016

    Table 7–3: Influenza Vaccine Market – Licensing Agreement,2007 – 2016

    Table 7–4: Influenza Vaccine Market – Exclusive Agreement,2009 – 2016

    Table 7–5: Influenza Vaccine Market – Distribution Agreement,2005 – 2016

    Table 8–1: BiondVax Pharmaceuticals Ltd. – Clinical Trials

List Of Figures, Charts and Diagrams
in Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022 [Published by DPI Research]

List of Figures


Figure 2–1: Top Seven Countries – Seasonal Influenza Vaccine Market (Million US$),2010 – 2015

Figure 2–2: Top Seven Countries – Forecast for Seasonal Influenza Vaccine Market (Million US$),2016 – 2022

Figure 2–3: Top Seven Countries – Number of Persons Vaccinated with Influenza Vaccine(Million),2010 – 2015

Figure 2–4: Top Seven Countries – Forecast for Number of Persons Vaccinated with Influenza Vaccine(Million),2016 – 2022

Figure 2–5: Top Seven Countries – Seasonal Influenza Vaccine Market Share (Percent),2010 – 2015

Figure 2–6: Top Seven Countries – Forecast for Seasonal Influenza Vaccine Market Share (Percent),2016 – 2022

Figure 2–7: Top Seven Countries – Number of Persons Vaccinated with Influenza Vaccine Share(Percent),2010 – 2015

Figure 2–8: Top Seven Countries – Forecast for Number of Persons Vaccinated with Influenza Vaccine Share(Percent),2016 – 2022


Figure 4–1: United States – Seasonal Influenza Vaccine Market (Million US$),2010 – 2015

Figure 4–2: United States – Forecast for Seasonal Influenza Vaccine Market (Million US$),2016 – 2022

Figure 4–3: United States – Total Number of Persons Vaccinated(Thousand), 2010 – 2015

Figure 4–4: United States – Forecast for Total Number of Persons Vaccinated(Thousand), 2016 – 2022

Figure 4–5: United States – Number of Children Vaccinated(Thousand),2010 – 2015

Figure 4–6: United States – Forecast for Number of Children Vaccinated(Thousand),2016 – 2022

Figure 4–7: United States – Number of Adults Vaccinated(Thousand),2010 – 2015

Figure 4–8: United States – Forecast for Number of Adults Vaccinated(Thousand),2016 – 2022

Figure 4–9: Germany – Seasonal Influenza Vaccine Market (Million US$),2010 – 2015

Figure 4–10: Germany – Forecast for Seasonal Influenza Vaccine Market (Million US$),2016 – 2022

Figure 4–11: Germany – Total Number of Persons Vaccinated(Thousand), 2010 – 2015

Figure 4–12: Germany – Forecast for Total Number of Persons Vaccinated(Thousand), 2016 – 2022

Figure 4–13: Germany – Number of 60+ Years of Age Persons Vaccinated(Thousand),2010 – 2015

Figure 4–14: Germany – Forecast for Number of 60+ Years of Age Persons Vaccinated(Thousand),2016 – 2022

Figure 4–15: Germany – Number of Pregnant Women Vaccinated(Thousand),2010 – 2015

Figure 4–16: Germany – Forecast for Number of Pregnant Women Vaccinated(Thousand),2016 – 2022

Figure 4–17: Germany – Number of Chronic Medical Condition Persons Vaccinated(Thousand),2010 – 2015

Figure 4–18: Germany – Forecast for Number of Chronic Medical Condition Persons Vaccinated(Thousand),2016 – 2022

Figure 4–19: Germany – Number of Healthcare Workers Vaccinated(Thousand),2010 – 2015

Figure 4–20: Germany – Forecast for Number of Healthcare Workers Vaccinated(Thousand),2016 – 2022

Figure 4–21: France – Seasonal Influenza Vaccine Market (Million US$),2010 – 2015

Figure 4–22: France – Forecast for Seasonal Influenza Vaccine Market (Million US$),2016 – 2022

Figure 4–23: France – Total Number of Persons Vaccinated(Thousand), 2010 – 2015

Figure 4–24: France – Forecast for Total Number of Persons Vaccinated(Thousand), 2016 – 2022

Figure 4–25: France – Number of 65+ Years of Age Persons Vaccinated(Thousand),2010 – 2015

Figure 4–26: France – Forecast for Number of 60+ Years of Age Persons Vaccinated(Thousand),2016 – 2022

Figure 4–27: France – Number of Pregnant Women Vaccinated(Thousand),2010 – 2015

Figure 4–28: France – Forecast for Number of Pregnant Women Vaccinated(Thousand),2016 – 2022

Figure 4–29: France – Number of Chronic Medical Condition Persons Vaccinated(Thousand),2010 – 2015

Figure 4–30: France – Forecast for Number of Chronic Medical Condition Persons Vaccinated(Thousand),2016 – 2022

Figure 4–31: France – Number of Healthcare Workers Vaccinated(Thousand),2010 – 2015

Figure 4–32: France – Forecast for Number of Healthcare Workers Vaccinated(Thousand),2016 – 2022

Figure 4–33: Italy – Seasonal Influenza Vaccine Market (Million US$),2010 – 2015

Figure 4–34: Italy – Forecast for Seasonal Influenza Vaccine Market (Million US$),2016 – 2022

Figure 4–35: Italy – Total Number of Persons Vaccinated(Thousand), 2010 – 2015

Figure 4–36: Italy – Forecast for Total Number of Persons Vaccinated(Thousand), 2016 – 2022

Figure 4–37: Italy – Number of 65+ Years of Age Persons Vaccinated(Thousand),2010 – 2015

Figure 4–38: Italy – Forecast for Number of 65+ Years of Age Persons Vaccinated(Thousand),2016 – 2022

Figure 4–39: Italy – Number of Pregnant Women Vaccinated(Thousand),2010 – 2015

Figure 4–40: Italy – Forecast for Number of Pregnant Women Vaccinated(Thousand),2016 – 2022

Figure 4–41: Italy – Number of Chronic Medical Condition Persons Vaccinated(Thousand),2010 – 2015

Figure 4–42: Italy – Forecast for Number of Chronic Medical Condition Persons Vaccinated(Thousand),2016 – 2022

Figure 4–43: Italy – Number of Healthcare Workers Vaccinated(Thousand),2010 – 2015

Figure 4–44: Italy – Forecast for Number of Healthcare Workers Vaccinated(Thousand),2016 – 2022

Figure 4–45: United Kingdom – Seasonal Influenza Vaccine Market (Million US$),2010 – 2015

Figure 4–46: United Kingdom – Forecast for Seasonal Influenza Vaccine Market (Million US$),2016 – 2022

Figure 4–47: United Kingdom – Total Number of Persons Vaccinated(Thousand), 2010 – 2015

Figure 4–48: United Kingdom – Forecast for Total Number of Persons Vaccinated(Thousand), 2016 – 2022

Figure 4–49: United Kingdom – Vaccination Coverage Rate (%)

Figure 4–50: United Kingdom – Number of Children Vaccinated(Thousand),2010 – 2015

Figure 4–51: United Kingdom – Forecast for Number of Children Vaccinated(Thousand),2016 – 2022

Figure 4–52: United Kingdom – Number of 65+ Years of Age Persons Vaccinated(Thousand),2010 – 2015

Figure 4–53: United Kingdom – Forecast for Number of 65+ Years of Age Persons Vaccinated(Thousand),2016 – 2022

Figure 4–54: United Kingdom – Number of Pregnant Women Vaccinated(Thousand),2010 – 2015

Figure 4–55: United Kingdom – Forecast for Number of Pregnant Women Vaccinated(Thousand),2016 – 2022

Figure 4–56: United Kingdom – Number of Chronic Medical Condition Persons Vaccinated(Thousand),2010 – 2015

Figure 4–57: United Kingdom – Forecast for Number of Chronic Medical Condition Persons Vaccinated(Thousand),2016 – 2022

Figure 4–58: United Kingdom – Number of Healthcare Workers Vaccinated(Thousand),2010 – 2015

Figure 4–59: United Kingdom – Forecast for Number of Healthcare Workers Vaccinated(Thousand),2016 – 2022

Figure 4–60: Spain – Seasonal Influenza Vaccine Market (Million US$),2010 – 2015

Figure 4–61: Spain – Forecast for Seasonal Influenza Vaccine Market (Million US$),2016 – 2022

Figure 4–62: Spain – Total Number of Persons Vaccinated(Thousand), 2010 – 2015

Figure 4–63: Spain – Forecast for Total Number of Persons Vaccinated(Thousand), 2016 – 2022

Figure 4–64: Spain – Number of 65+ Years of Age Persons Vaccinated(Thousand),2010 – 2015

Figure 4–65: Spain – Forecast for Number of 65+ Years of Age Persons Vaccinated(Thousand),2016 – 2022

Figure 4–66: Spain – Number of Pregnant Women Vaccinated(Thousand),2010 – 2015

Figure 4–67: Spain – Forecast for Number of Pregnant Women Vaccinated(Thousand),2016 – 2022

Figure 4–68: Spain – Number of Chronic Medical Condition Persons Vaccinated(Thousand),2010 – 2015

Figure 4–69: Spain – Forecast for Number of Chronic Medical Condition Persons Vaccinated(Thousand),2016 – 2022

Figure 4–70: Spain – Number of Healthcare Workers Vaccinated(Thousand),2010 – 2015

Figure 4–71: Spain – Forecast for Number of Healthcare Workers Vaccinated(Thousand),2016 – 2022

Figure 4–72: Japan – Seasonal Influenza Vaccine Market (Million US$),2010 – 2015

Figure 4–73: Japan – Forecast for Seasonal Influenza Vaccine Market (Million US$),2016 – 2022

Figure 4–74: Japan – Total Number of Persons Vaccinated(Thousand), 2010 – 2015

Figure 4–75: Japan – Forecast for Total Number of Persons Vaccinated(Thousand), 2016 – 2022

Figure 4–76: Japan – Number of Children Vaccinated(Thousand), 2010 – 2015

Figure 4–77: Japan – Forecast for Number of Children Vaccinated(Thousand), 2016 – 2022

Figure 4–78: Japan – Number of 65+ Years of Age Persons Vaccinated(Thousand),2010 – 2015

Figure 4–79: Japan – Forecast for Number of 65+ Years of Age Persons Vaccinated(Thousand),2016 – 2022

Figure 4–80: Japan – Number

Additional Details

Publisher

DPI Research

Publisher Information

We at DPI Research strongly believe that business should be based on thorough research base. All the business or individual decisions should be based upon a well formulated strategy based on intensive research.



DPI Research  is a market research, social research and marketing company which delivers all the information required to solve business and marketing problems. DPI Research is a business solutions firm which offer bespoke syndicated research reports, custom research solutions, marketing services and social research across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.



DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.



DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insights for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Reference

28551 |

Number of Pages

205

Report Format

PDF

DPI Research Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Seasonal Influenza: Competitive Landscape to 2026
Seasonal Influenza: Competitive Landscape to 2026SummaryInfluenza, often referred to as the flu, is ...
08 Nov 2018 by Global Data USD $3,495 More Info
EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025
EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025SummaryInfluenza, commonly known a...
01 Nov 2016 by Global Data USD $3,995 More Info
EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025
EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025SummaryInfluenza, commonly known a...
01 Nov 2016 by Global Data USD $3,995 More Info
PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025
PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025SummaryIn...
01 Nov 2016 by Global Data USD $10,995 More Info
Seasonal Influenza Vaccines - US Drug Forecast and Market Analysis to 2025
Seasonal Influenza Vaccines - US Drug Forecast and Market Analysis to 2025SummaryInfluenza, often re...
01 Nov 2016 by Global Data USD $4,995 More Info
Seasonal Influenza Vaccines - Japan Drug Forecast and Market Analysis to 2025
Seasonal Influenza Vaccines - Japan Drug Forecast and Market Analysis to 2025SummaryInfluenza, often...
01 Nov 2016 by Global Data USD $4,995 More Info
Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016
Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial...
30 Sep 2016 by Global Data USD $2,500 More Info
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinica...
27 Jul 2016 by Global Data USD $2,500 More Info
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinica...
27 Jul 2016 by Global Data USD $2,500 More Info
Seasonal Influenza Global Clinical Trials Review, H2, 2015
Seasonal Influenza Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report,...
30 Dec 2015 by Global Data USD $2,500 More Info

This report is published by DPI Research

We at DPI Research strongly believe that business should be based on thorough research base. All the business or individual decisions should be based upon a well formulated strategy based on intensive research.

DPI Research  is a market research, social research and marketing company which delivers all the information required to solve business and marketing problems. DPI Research is a business solutions firm which offer bespoke syndicated research reports, custom research solutions, marketing services and social research across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.

DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insights for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Download Free Report Summary PDF

Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022 [Published by DPI Research] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...